Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Voided Urine Fluorescence In Situ Hybridization Testing for Upper Tract Urothelial Carcinoma Surveillance

21 Jul 2010

Abstract excerpt

PURPOSE: Fluorescence in situ hybridization is gaining popularity for transitional cell carcinoma screening. We determined the accuracy of fluorescence in situ hybridization for identifying upper tract transitional cell carcinoma. MATERIALS AND METHODS: A retrospective review of our upper tract transitional cell carcinoma database from 2005 to 2008 identified 35 patients with upper tract transitional cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Esophageal Cancer Research and Treatment
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20643443
DOI: 10.1016/j.juro.2010.05.023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Voided Urine Fluorescence In Situ Hybridization Testing for Upper Tract Urothelial Carcinoma SurveillancePMID 20643443Read ↗

Use of a Multitarget Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With HematuriaSemantic proximity Read ↗

Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinomaSemantic proximity Read ↗

Urine cytology suspicious for urothelial carcinoma: Prospective follow-up of cases using cytology and urine biomarker-based ancillary techniques.Semantic proximity Read ↗

Fluorescence in situ hybridization for detecting urothelial carcinomaSemantic proximity Read ↗

Cost-Effectiveness of Fluorescence In Situ Hybridization in Patients with Atypical Cytology for the Detection of Urothelial CarcinomaSemantic proximity Read ↗

Multiprobe Fluorescence in situ Hybridization (UroVysion) for the Detection of Urothelial Carcinoma – FISHing for the Right CatchSemantic proximity Read ↗

Fluorescence-in-situ-hybridization in the Surveillance of Urothelial Cancers: Can Use of Cystoscopy or Ureteroscopy be Deferred?Semantic proximity Read ↗

Bladder Cancer Detection Using FISH (UroVysion Assay)Semantic proximity Read ↗

Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancerSemantic proximity Read ↗

Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancerSemantic proximity Read ↗

Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancerSemantic proximity Read ↗

Uroplakin as a marker for typing metastatic transitional cell carcinoma on fine-needle aspiration specimens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.